HBI Deals+Insights / M&A/IPOs

Meinian ups bid to over $1.7bn for iKang

The consortium led by quoted outpatient operator Meinian has raised its bid for rival Chinese outpatient group, iKang, from $23.50 to US$25 per American Depository Share (ADS). That is 40% higher than the offer of US$17.80 from the management-backed consortium led by former iKang CEO, Zhang Ligang which is backed by Canadian pension fund, Ontario Teachers’ Pension Plan (OTTP), and the founder of Chinese online giant, Alibaba.

We would welcome your thoughts on this story. Email your views to Max Hotopf or call 0207 183 3779.